Exeter academics awarded grants for pioneering fungal research
Two scientists from the The MRC Centre for Medical Mycology, based at the University of Exeter, have received prestigious Springboard Awards from The Academy of Medical Sciences for their research into a deadly fungal disease.
Biomedical researchers Dr Liliane Mukaremera and Dr Carolina Coelho will both use the funding to support their investigations into the fungal pathogen
Cryptococcus neoformans.
Meningitis caused by the pathogen kills many people with weakened immunity, such as those with cancer, organ transplant recipients and HIV/AIDS. In HIV/AIDS patients alone, this meningitis kills over 181,000 people each year even with antifungal treatment.
Dr Carolina Coelho and Dr Liliane Mukaremera
Two scientists from the The MRC Centre for Medical Mycology, based at the University of Exeter, have received prestigious Springboard Awards from The Academy of Medical Sciences for their research into a deadly fungal disease.
Biomedical researchers Dr Liliane Mukaremera and Dr Carolina Coelho will both use the funding to support their investigations into the fungal pathogen Cryptococcus neoformans.
Meningitis caused by the pathogen kills many people with weakened immunity, such as those with cancer, organ transplant recipients and HIV/AIDS. In HIV/AIDS patients alone, this meningitis kills over 181,000 people each year even with antifungal treatment.
Vaccines are being rolled out; in some places, people are eating in restaurants again; even some cinemas are opening up. A year after the World Health Organization declared COVID-19 to be a pandemic, the world is slowly returning to a semblance of what it was before the coronavirus began its devastating march.
And with trillions of dollars of stimulus measures acting like a financial shot in the arm of the global economy, stock markets have surged as forecasters such as the Organisation for Economic Co-operation and Development ramp up their projections for economic growth.
But some economists fear that the underlying causes of the pandemic – among them our pursuit of never-ending economic growth at the expense of the world’s limited natural resources – have yet to be addressed.
More travel executives get their mission-critical industry news from Skift than any other source on the planet.Tell me more
Jaguar Land Rover has sold a majority stake in its ridehailing division Havn to chauffeur service Blacklane, signaling the latest U-turn by a car manufacturer in the urban travel space that sought big upsides with corporate travelers.
Havn was launched by Studio 107, a division of InMotion Ventures, Jaguar Land Rover’s venture capital and mobility services arm, in March last year. InMotion has also invested in Lyft, among other startups.
But now Jaguar Land Rover joins rivals BMW, Daimler and Ford in having to rethink how it can tap into the lucrative urban travel sector.